Revolution Medicines, Inc. (RVMD) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2018: $1.50M2019: $2.59M2020: $2.93M2021: $6.53M2022: $10.82M2023: $7.73M2024: $10.31M2025: $15.99M$15.99M
2018Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$15.99M+55.1%
2024$10.31M+33.4%
2023$7.73M-28.5%
2022$10.82M+65.7%
2021$6.53M+122.6%
2020$2.93M+13.3%
2019$2.59M+72.7%
2018$1.50M